IL6 and schizophrenia: The exacerbated decrease in ABCG2 in the “high inflammation” schizophrenia subgroup is consistent with evidence showing that treatment with IL-1β, IL-6 and TNFα reduces both mRNA and protein expression of endothelial ABCG2 in vitro [65].